Testing the Effectiveness of AI Chatbots to Improve Public Knowledge and Attitudes Towards Depression
Effectiveness and Usability of AI-based Chatbots in Improving Depression Literacy, Attitudes Toward Depression, Help-Seeking Intentions, and Confidence in Helping Others: a Randomized Controlled Trial
1 other identifier
interventional
200
1 country
1
Brief Summary
The purpose of this randomized controlled trial (RCT) is to find out whether using AI Chatbots can help the public better understand depression, reduce negative attitudes towards it, and encourage more people to seek help when needed. The study will also explore whether the Chatbot can help individuals feel more confident in supporting others who might be experiencing depression. Participants will be randomly assigned to either:
- 1.AI-PsyTeacher Group: Participants interact with the AI psychology teacher "Liran" to complete three progressive tasks (identifying depression symptoms, learning coping strategies, and understanding prevention). This group assesses the independent role of AI in mental health education.
- 2.AI-Integrated Intervention Group: Participants first learn with the AI psychology teacher "Liran" and then interact with the AI-simulated depressed patient "Beibei" to complete three tasks (identifying issues, teaching coping strategies, and creating a prevention plan). This group examines the combined effect of AI teaching and patient simulation.
- 3.Traditional Psychoeducation Group (Control): Participants gain depression-related knowledge by reading traditional educational materials and watching a first-person experience video. This group serves as the control to compare AI interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 10, 2025
CompletedFirst Submitted
Initial submission to the registry
February 24, 2025
CompletedFirst Posted
Study publicly available on registry
March 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2025
CompletedMarch 5, 2025
March 1, 2025
2 months
February 24, 2025
March 3, 2025
Conditions
Outcome Measures
Primary Outcomes (7)
Depression Literacy Scale (D-Lit)
The Depression Literacy Scale is a 22-question survey that assesses a person's depression literacy. The questions are rated on a scale of "true", "false", or "I don't know". Each correct answer is worth one point, with higher scores indicating a higher level of depression literacy.
pre-intervention, immediately after the intervention, 1-week follow-up, 4-week follow-up, 12-week follow-up
Depression Literacy Questionnaire
The Depression Literacy Questionnaire assesses mental health literacy specific to depression. It is a self-developed, 31-item questionnaire designed to assess participants' confidence in providing support to individuals experiencing depression. Each item is rated on a 5-point Likert scale, ranging from 1 ("Strongly Disagree") to 5 ("Strongly Agree"), with higher scores indicating greater depression literacy.
pre-intervention, immediately after the intervention, 1-week follow-up, 4-week follow-up, 12-week follow-up
Depression Stigma Scale (DSS)
The Depression Stigma Scale is designed to measure stigma associated with depression. It has two subscales which measure two different types of stigma: personal and perceived. The Personal Stigma Subscale measures stigma in the respondents own attitudes towards depression by asking them to indicate how strongly they personally agree with nine statements about depression. The Perceived Stigma Subscale measures the respondent's perception about the attitudes of others towards depression by asking them to indicate what they think most other people believe about the same nine statements. Responses to each item are measured on a five-point scale (ranging from zero 'strongly disagree' to four 'strongly agree'). Higher scores indicate higher levels of depression stigma.
pre-intervention, immediately after the intervention, 1-week follow-up, 4-week follow-up, 12-week follow-up
Acquisition Questionnaire (AQ-9)
The Attribution Questionnaire (AQ) is a 9-item self-report assessment tool designed to measure public stigma towards people with mental illnesses. This version assesses emotional reaction and discriminatory responses based on answers to a hypothetical vignette about a man with depression named Xiao Li. Responses assessing stigma towards Xiao Li are in the form of 9 items rated on a Likert scale ranging from 1 (not at all) to 9 (very much).
pre-intervention, immediately after the intervention, 1-week follow-up, 4-week follow-up, 12-week follow-up
General Help-Seeking Questionnaire (GHSQ)
The General Help-Seeking Questionnaire (GHSQ) in this study is an adapted 12-item version designed to fit Chinese cultural contexts. It assesses an individual's intentions to seek help for personal or emotional problems from both formal sources (e.g., mental health professionals, doctors) and informal sources (e.g., family, friends). Each item is rated on a 7-point Likert scale, ranging from 1 ("Extremely Unlikely") to 7 ("Extremely Likely"), with higher scores indicating a greater likelihood of seeking help.
pre-intervention, immediately after the intervention, 1-week follow-up, 4-week follow-up, 12-week follow-up
System Usability Scale (SUS)
The System Usability Scale (SUS) in this study is an adapted 9-item version designed to assess the usability of AI-based chatbots. It evaluates participants' perceptions of the ease of use, effectiveness, efficiency, and overall user experience of the chatbots. The scale uses a 5-point Likert scale, ranging from 1 ("Strongly Disagree") to 5 ("Strongly Agree"), with higher scores indicating better perceived usability. Participants will complete the adapted SUS separately for both the AI Depression Education Teacher and the AI Depression Patient Simulation ("Beibei"). The adapted SUS maintains the core usability assessment principles of the original scale while being tailored for AI-driven conversational agents.
immediately after the intervention
Confidence in Helping Others Scale
The Confidence in Helping Others Scale is a self-developed, 19-item questionnaire designed to measure participants' confidence in providing support to individuals experiencing mental health issues. Each item is rated on a 5-point Likert scale, ranging from 1 ("Strongly Disagree") to 5 ("Strongly Agree"), with higher scores indicating greater confidence in recognizing depressive symptoms, offering emotional support, and encouraging help-seeking.
pre-intervention, immediately after the intervention, 1-week follow-up, 4-week follow-up, 12-week follow-up
Secondary Outcomes (4)
Patient Health Questionnaire (PHQ)
pre-intervention, immediately after the intervention, 1-week follow-up, 4-week follow-up, 12-week follow-up
General Anxiety Disorder (GAD-7)
pre-intervention, immediately after the intervention, 1-week follow-up, 4-week follow-up, 12-week follow-up
Basic Empathy Scale in Adults (BES-A)
pre-intervention, immediately after the intervention, 1-week follow-up, 4-week follow-up, 12-week follow-up
Mental Health-Related Behavior Questionnaire
pre-intervention, 4-week follow-up, 12-week follow-up
Study Arms (3)
AI Depression Education Teacher + AI Depression Patient Simulation Group
EXPERIMENTALParticipants in this group will interact with two AI-based chatbots, one after the other: First Chatbot (Psychoeducation Phase): The first chatbot is designed to provide psychoeducation about depression. Participants will interact with the chatbot to learn key information, such as common symptoms of depression, causes, treatment options, coping strategies, and how to provide emotional support to others experiencing depression. The goal of this phase is to improve participants' understanding of depression and reduce stigma. Second Chatbot (Empathy and Support Practice Phase): After completing the psychoeducation phase, participants will interact with a second chatbot simulating a person experiencing depression. This chatbot will simulate real-life conversations, allowing participants to practice empathetic communication, recognize signs of depression, and offer appropriate emotional support.
Control Group
ACTIVE COMPARATORParticipants in this group will not receive any intervention or access to the Chatbots. Participants will be directed to a depression-related article and a video describing the lived experience of a depression patient. Participants in this group will complete the same baseline and post-study assessments as those in the intervention group, which include measures of depression literacy, attitudes toward depression, help-seeking intentions, and confidence in helping others.
AI Depression Education Teacher Only Group
EXPERIMENTALParticipants will interact with the AI Depression Education Teacher, an interactive chatbot designed to provide psychoeducation on depression. The chatbot covers topics such as depression symptoms, causes, treatment options, and ways to support individuals experiencing depression. Participants engage in structured conversations and receive real-time feedback to reinforce learning.
Interventions
The intervention consists of two AI-based chatbots designed to enhance depression literacy, reduce stigma, and improve confidence in supporting others with depression. AI Depression Education Teacher - This chatbot provides interactive psychoeducation on depression, covering symptoms, causes, treatments, and ways to support others. Participants engage in a structured conversation to enhance their understanding and receive real-time feedback. AI Depression Patient Simulation ("Beibei") - Participants interact with a simulated individual experiencing depression to practice empathetic communication and support strategies. Through guided conversations, they learn to recognize depressive symptoms, offer emotional support, and encourage help-seeking. This two-phase intervention provides both knowledge and practical experience in a safe, interactive environment. Participants will engage with both chatbots sequentially within a one-hour session.
This intervention consists of interaction with an AI chatbot, i.e., AI Depression Education Teacher, which provides interactive psychoeducation on depression, covering symptoms, causes, treatments, and ways to support others.
The intervention contains standard psychoeducation materials about depression. Participants will be directed to: A depression-related article - Provides general information about depression, including its symptoms, causes, and treatment options. A video describing the lived experience of a depression patient - Shares a personal story to help participants understand the real-life impact of depression.
Eligibility Criteria
You may qualify if:
- Adults aged 18 to 65.
- General population, non-clinical individuals.
- No history of diagnosed mental disorders or current mental health diagnosis.
- Ability to complete AI interactions and related tasks via the internet or mobile devices.
- Native Chinese speakers.
- Willingness to participate in the study and sign an informed consent form.
You may not qualify if:
- History of mental disorders or self-reported current mental health issues.
- Currently undergoing psychological counseling.
- Inability to use mobile or internet devices properly.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking university
Beijing, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 24, 2025
First Posted
March 5, 2025
Study Start
February 10, 2025
Primary Completion
March 30, 2025
Study Completion
March 30, 2025
Last Updated
March 5, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share